Jew World Order

By Derrick Broze

The American Heart Association has released a statement recommending meditation as a way to potentially reduce the risk of heart disease. 

The American Heart Association has joined the chorus of voices recognizing the benefits of a regular meditation practice. In a statement titled, “Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association,” the AHA calls meditation a “potential attractive cost‐effective adjunct to more traditional medical therapies.”

The AHA conducted a systematic review of the studies on potential benefits of meditation on cardiovascular risk and found that, “Overall, studies of meditation suggest a possible benefit on cardiovascular risk.” The AHA did caution that the overall quality and quantity of study data is “modest”. The AHA looked at studies examining the physiological response to stress, smoking cessation, blood pressure reduction, insulin resistance and metabolic syndrome, endothelial function, inducible myocardial ischemia, and primary and secondary prevention of cardiovascular disease.

The non profit called for further research on meditation and cardiovascular risk, recommending researcher to “utilize randomized study design, be adequately powered to detect clinically meaningful benefit, include long‐term follow‐up, and be performed by those without inherent bias in outcome.”

Dr. Glenn Levine, chair of the AHA task force on clinical practice guidelines, told Reuters that meditation was not a cure all and should not be  undertaken as a substitute for well-established and recommended lifestyle and medicinal interventions.”

One of the reasons the American Heart Association chose to investigate the benefits of meditation is because of previous studies which have indicated that meditation can have positive effects on the brain.  The research examined by the AHA focused on sitting meditation such as Samatha, Vipassana, Mindfulness Meditation, Zazen (Zen Meditation), Raja Yoga, Loving-Kindness (Metta), Transcendental Meditation, and Relaxation Response. These meditations have been associated with lower levels of stress, anxiety, and depression, as well as improved sleep.

According to a recent analysis, mindfulness-based cognitive therapy may be more helpful than other treatments for people with recurring depression. The  study was conducted by a team with the University of Oxford in the UK. The researchers analyzed data from 1,258 participants from nine randomized controlled trials that compared mindfulness-based cognitive therapy (MBCT) to other treatments for recurring depression among people who were fully or partially in remission. Around 31 percent of participants receiving MBCT were less likely to have depression again after 60 weeks, compared to those who had received other treatments.

A 2015 study published in The Lancet medical journal found that Mindfulness-based cognitive therapy (MBCT) may be just as effective as pharmaceuticals when it comes to preventing chronic depression relapse. Researchers at Britain’s Oxford University and Plymouth University Peninsula Schools of Medicine and Dentistry conducted the first large-scale study to compare the treatment of chronic depression with MBCT and anti-depressants. They found very little difference in the results of the two different treatments, including a minimal difference in the cost of the mindfulness training versus the constant use of pharmaceuticals.